Abstract
Injuries to the hand and wrist are commonly 
encountered in athletes. Decisions regarding the most appropriate 
treatment, the timing of treatment, and return to play are made while 
balancing desires to resume athletic activities and sound orthopedic 
principles. Little recognition in the literature exists regarding the 
need for a different approach when treating these injuries in elite 
athletes and the timing to return to play.
This study explored the complexities of treating hand and wrist 
injuries in the elite athlete. Thirty-seven consultant hand surgeons for
 teams in the National Football League, National Basketball Association,
 and Major League Baseball completed a brief electronic survey about the
 management of 10 common hand injuries. Notable variability existed in 
responses for initial management, return to protected play, and return 
to unprotected play for all injuries, aside from near consensus 
agreement (94%) that elite athletes with stable proximal interphalangeal
 dislocations could immediately return to protected play. Basketball 
surgeons were less likely to recommend early return to protected play 
than non-basketball surgeons. Baseball surgeons were more likely to 
recommend early unprotected play after scaphoid fixation. Football 
surgeons were more likely to recommend earlier return to protected play 
after thumb ulnar collateral ligament injuries, whereas basketball 
surgeons were less likely to recommend earlier return to protected play.
This study demonstrated wide variability in how consultant hand 
surgeons approach the treatment of hand and wrist injuries. The findings
 emphasize the need to individually tailor treatment decisions to the 
patient’s desires and demands, particularly in high-performance 
athletes.
The authors are from the Division of Hand and Upper Extremity Surgery, Hospital for Special Surgery, New York, New York.
The authors have no relevant financial relationships to disclose.
Correspondence should be addressed to: Michelle Gerwin Carlson, MD, 
Division of Hand and Upper Extremity Surgery, Hospital for Special 
Surgery, 523 E 72nd St, 4th Floor, New York, NY 10021 
(carlsonm@hss.edu).
Injuries to the hand and wrist are commonly encountered in athletes.
1–3 
                             After arriving at a diagnosis, 
the treating physician must address the many considerations that make 
treating an athlete different than caring for other patients. Decisions 
regarding the most appropriate treatment, the timing of treatment, and 
circumstances surrounding return to play are made while balancing 
desires to resume athletic activities and sound orthopedic principles.
4 
                             The same complexities that 
differentiate the treatment of athletes from nonathletes are what 
distinguish the management of injuries in elite athletes.
5 
                             High-performance athletes are 
likely to have a different perspective than casual athletes, placing 
greater importance on return to play given the implications on their 
livelihood. Given these differences, expectations for treatment outcomes
 in elite athletes are likely to be higher than those of casual 
athletes. Although the literature is replete with case series and expert
 opinions regarding the management of hand and wrist injuries in 
athletes, little recognition exists regarding the need for a different 
approach when treating injuries in elite athletes and timing to return 
to play.
To further explore the complexities of treating hand and 
wrist injuries in elite athletes, the authors conducted a survey of 
consultant hand surgeons for professional football, basketball, and 
baseball teams in the United States. Physicians were asked about their 
practice of timing of surgery and return to play (both protected and 
unprotected) for 10 common hand injuries. The authors hypothesized 
opinions would vary widely regarding the treatment of hand and wrist 
injuries in elite athletes, with notable differences based on experience
 with athletes from different sports.
Materials and Methods
To
 generate the study cohort, team physicians for every team in the 
National Football League, National Basketball Association, and Major 
League Baseball were contacted and asked for the contact information for
 their consultant hand surgeon. Those 78 hand surgeons were requested to
 complete a brief electronic survey with questions about the management 
of metacarpal shaft fractures, scaphoid fractures, pisiform fractures, 
hamate hook fractures, thumb ulnar collateral ligament injuries, and 
dislocations of the proximal interphalangeal joint. This survey included
 questions about indications for surgery, return to protected play, and 
return for unprotected play (
Table 
                ). The survey items were derived from the senior 
author’s (M.G.C.) experience in treating professional athletes, 
including primary coverage of a National Basketball Association team. 
Invitations to complete the anonymous survey were distributed via e-mail
 using third-party software (SurveyMonkey, Palo Alto, California). One 
reminder to complete the survey was sent after the initial invitation. 
The research protocol was approved by the authors’ institutional review 
board prior to survey administration.
  
Crosstab
 calculations and chi-square analysis were performed using SPSS version 
19.0 software (IBM, Armonk, New York). Responses were compared by sport 
treated by the surgeon (baseball vs no baseball; football vs no 
football; basketball vs no basketball), by the number of sports treated 
(1 sport or more than 1 sport), and number of professional athletes 
treated (more or less than 12 per year). An a priori sample size 
calculation was not performed because a convenience sample of a limited 
cohort was planned.
 
Results
Thirty-seven
 consultant hand surgeons completed the survey, all of whom were 
affiliated with at least 1 professional sports team. Respondents were 
asked which sport they were currently affiliated with and were allowed 
to list more than 1 sport. Fifteen respondents reported that they 
treated elite athletes in only 1 sport and 22 reported that they treated
 elite athletes from more than 1 sport. The most commonly treated sports
 were baseball (n=22) and football (n=22), followed by basketball (n=19)
 and hockey (n=12). Eighteen of the respondents treated more than 12 
elite athletes in 1 year, whereas 19 treated less than 12 elite athletes
 in 1 year.
Metacarpal Fractures
Protected Play.
 Slightly more than half (n=21; 56.8%) of the 37 respondents allow elite
 athletes with nondisplaced metacarpal fractures to return to protected 
play at 3 to 4 weeks after injury, whereas 14 (37.8%) allow immediate 
return to protected play. Surgeons who treated basketball players were 
less likely to recommend early return to protected play than 
non-basketball surgeons (P=.047).
Unprotected Play. Most respondents (n=27; 73%) waited until 4 to 8 weeks after injury for unprotected play to resume.
Scaphoid Fractures
Protected Play.
 Slightly more than half of the 37 respondents (n=19; 51.4%) allow elite
 athletes to return to protected play 4 to 6 weeks after treatment of a 
nondisplaced a scaphoid fracture. Twelve surgeons (32.4%) allow elite 
athletes to return to protected play immediately.
Unprotected Play.
 Opinions regarding return to unprotected play were more variable: 9 
(24.3%) allow return to unprotected play after 4 to 6 weeks, 18 (48.6%) 
after 6 to 12 weeks, and 10 (27%) wait more than 12 weeks. Surgeons who 
treated baseball players were more likely than non-baseball surgeons to 
recommend their patients to unprotected play earlier after treatment of a
 nondisplaced a scaphoid fracture (P=.005). Surgeons who treated 
athletes from more than 1 sport were also more aggressive in 
recommending earlier unprotected play after treatment of a non-displaced
 a scaphoid fracture (P=.042).
Pisiform Fractures
Treatment Decision.
 For elite athletes with pisiform fractures, 11 (29.7%) surgeons allow 
immediate return to play, 7 (18.9%) recommend immediate excision, 8 
(21.6%) recommend splinting for 4 weeks followed by return to sport, 3 
(8.1%) recommend excision after 4 weeks if not healed, and 8 (21.6%) 
recommend excision after 8 weeks if not healed.
Surgeons who treat
 more than 12 elite athletes in 1 year are more likely to recommend 
immediate treatment (either immediate return to play or immediate 
excision), whereas surgeons who treat less than 12 elite athletes in 1 
year are more likely to explore delayed treatment options (P=.043).
Hamate Hook Fractures
Protected Play.
 Following excision of hamate hook fractures, 11 (30.6%) of 36 surgeons 
allow immediate return to protected play, 19 (52.8%) allow return to 
protected play after 2 weeks, and 6 (16.7%) of surgeons allow return to 
protected play in 6 weeks.
Unprotected Play. More than half
 of the 37 surgeons (n=20; 54.1%) allow return to unprotected play at 6 
weeks, 15 (40.5%) allow return to unprotected play at 2 weeks, and 1 
(2.7%) allows immediate return to unprotected play.
Thumb Ulnar Collateral Ligament Tears
Treatment Decision.
 For an elite athlete with a complete thumb ulnar collateral ligament 
tear, 14 (37.8%) of the 37 surgeons recommended immediate repair, 12 
(32.4%) recommended repair at the end of the season (if within 6 weeks),
 3 (8.1%) recommended repair at the end of the season (if within 3 
months), 7 (18.9%) recommended repair at the end of the season (even if 
beyond 6 months from injury), and 1 (2.7%) surgeon recommended 
nonoperative treatment.
Protected Play. For return to 
protected play after thumb ulnar collateral ligament injury, 5 (13.9%) 
of 36 surgeons recommended immediate return, 20 (55.6%)recommended 
waiting 2 weeks, 10 (27.8%) recommended waiting 6 weeks, and 1 (2.8%) 
recommended waiting 3 months. Surgeons who treat football players are 
more likely to recommend earlier return to protected play than 
non-football surgeons (P=.023), whereas surgeons who treat 
basketball players are less likely to recommend earlier return to 
protected play than non-basketball surgeons (P=.021).
Unprotected Play. For return to unprotected play, most of the 36 surgeons (n=23; 63.9%) recommended waiting 3 months.
Stable Proximal Interphalangeal Joint Dislocation
Protected Play.
 Almost all 36 (n=34; 94.4%) surgeons recommended immediate return to 
protected play for elite athletes with stable proximal interphalangeal 
dislocations, whereas 2 (5.6%) surgeons recommended waiting 4 weeks.
Unprotected Play.
 More than one-quarter (n=11; 29.7%) of the 37 surgeons recommended 
returning to unprotected play after 4 weeks, 14 (37.8%) recommended 
waiting 4 to 8 weeks, and 3 (8.1%) surgeons recommended a period of more
 than 3 months before return to unprotected play.
 
Discussion
Increasing awareness of the influence of patient expectations on treatment outcomes
6 
                             indicates that surgeons need to 
be more cognizant of what patients desire and expect from treatment. 
This is particularly true when treating athletes who not only 
participate in sports for recreational or fitness pursuits but also rely
 on their athletic abilities for their livelihood. Recognition of elite 
athletes as a distinct patient population is important in allowing 
surgeons and patients to participate in shared decision making that 
balances the desires of immediate return to play with long-term 
sequelae.
4 
                             In the current study, the authors
 demonstrated wide variability in how consultant hand surgeons approach 
the treatment of hand and wrist injuries. The individual experiences of 
the respondents have shaped their approaches to management, as the 
current results indicate that those who care for athletes of different 
sports occasionally have significantly different thresholds for return 
to protected and unprotected play. Treatment is tailored to the demands 
of the individual athletes and their sports, as evidenced by instances 
of more conservative management among surgeons who treat basketball 
players, whose sport requires distinct dexterity with a short interval 
between games.
Although this survey provides a glimpse into the 
decision making of consultant hand surgeons, it is beyond the scope of 
this investigation to indicate whether these treatment recommendations 
predict outcomes, and this research needs to be done. Surgeons must 
carefully counsel patients about the risks and benefits of each nuanced 
aspect of treatment and, in situations where athletic performance has 
deep-seated career or financial implications, informed and shared 
decision making is critical to ensure satisfactory outcomes.
As 
the authors demonstrated, a major challenge in treating elite athletes 
is determining the appropriate time frame for return to play. The 
benefits of early return must be weighed against the consequences of 
potential complications. Although all patients with fractures who return
 to play too early may experience delayed healing or nonunion, the 
difficulty in treating these sequelae vary depending on the type of 
fracture. Metacarpal shaft nonunions or malunions can be readily treated
 with internal fixation and bone grafting (if needed), whereas pisiform 
nonunions can be treated with excision. However, premature return to 
play after scaphoid fracture can create unnecessarily challenging 
treatment scenarios because an acute fracture that is easily treatable 
may develop into a difficult-to-treat nonunion. Because the latter may 
have substantial negative short- and long-term effects, return to play 
after scaphoid fractures should be approached with more caution. For 
example, the authors prefer to confirm at least 50% healing with 
computed tomography before allowing return to play. Conversely, for 
proximal interphalangeal dislocations, the risk of a redislocation is 
small, especially with buddy taping, and the likelihood of being able to
 reduce a redislocated joint is high. Surgeons have a low threshold to 
allow immediate return to play for this injury.
The main 
limitations of the current study are centered on the survey tool. The 
injuries included in the survey are those that were felt to be commonly 
encountered, but with at least mild to moderate controversy regarding 
treatment. The survey was not designed to assess actual treatment 
decisions, but rather to demonstrate variability in decision making 
among consultant hand surgeons. A formalized validation process was not 
undertaken, but the survey was internally piloted among the hand surgery
 faculty of the authors’ academic institution. The response rate of the 
study cohort was 47% (37 of 78 consultant hand surgeons), which is less 
than desired but acceptable when compared with other surveys of 
professional surgeon groups.
7–11 
                             It is possible that the results 
may have been different if a larger proportion of the study cohort had 
completed the survey. Despite these limitations, the authors believe 
that the study has demonstrated the amount of variability in the 
decision making of consultant hand surgeons.
 
Conclusion
The
 findings emphasize the need to individually tailor treatment decisions 
to patients’ desires and demands, particularly in high-performance 
athletes. This survey has spurred the formation of a group of consultant
 hand surgeons who are now collaborating for multicenter prospective 
studies of hand and wrist injuries in elite athletes.
CJ Dy; E Khmelnitskaya; KA Hearns; MG Carlson: Opinions Regarding the Management of Hand and Wrist Injuries in Elite Athletes.Orthopedics; June 2013 - Volume 36 · Issue 6: 815-819